Clinical Trials Arena on MSN
Compass stock heads north on psychedelic’s Phase III TRD success
Compass will now seek approval for COMP360, which could become the first classic psychedelic to gain the FDA’s blessing.
The proposed $7.5 billion settlement, filed in Missouri's 22nd Judicial Circuit on Tuesday, comes one month after the U.S.
U.S. District Chief Judge Leigh Martin May of the Northern District of Georgia planned a hearing Tuesday on whether to move ahead with the bellwether plan after a federal jury sided with defendant ...
21h
Shaping Wealth Taps Fintech Veteran Corey Westphal as CRO to Power AI Expansion in Wealth Management
Wealthtech veteran to lead growth as firm expands from education company to embedded AI platform With Lydia, Shaping ...
Samsung is gearing up for the launch of its next-generation Galaxy S26 series on February 25. While there is no official confirmation regarding the specifications yet, reports and leaks have already ...
Join us in exploring an incredible custom design in Dallas that's defined by curves and organic appeal, courtesy of Select Custom Homes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results